ARTICLE | Company News
Dyax management update
March 11, 2013 7:00 AM UTC
Dyax Corp. (NASDAQ:DYAX), Burlington, Mass. Business: Inflammation, Ophthalmic Departing: Ivana Magovcevic-Liebisch as EVP and COO, effective March 29, while remaining a consultant ...